v3.26.1
Revenue Recognition
 3 Months Ended
Mar. 28, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Our policies for recognizing sales have not changed from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. The Company attributes net sales to external customers to the U.S. and to all foreign countries based on the legal entity from which the sale originated. The Company had product sales to one customer totaling $14,822 representing 11.2% of net sales, primarily in the U.S. reporting segment during the three months ended March 28, 2026. The same customer had product sales of $13,594 representing 11.0% of net sales during the three months ended March 29, 2025.
The following table presents the Company’s net sales disaggregated by major business within each segment as follows:
Three Months Ended
March 28, 2026March 29, 2025
U.S.
Pain Treatments
$56,157 $52,686 
Surgical Solutions42,541 40,844 
Restorative Therapies17,747 16,990 
Total U.S. net sales116,445 110,520 
International
Pain Treatments
7,269 6,232 
Surgical Solutions5,487 4,390 
Restorative Therapies2,888 2,734 
Total International net sales15,644 13,356 
Total net sales$132,089 $123,876